Finance
GSK Profit Beats Estimates on HIV, Cancer Medicines
GSK Plc’s profit was higher than analysts expected in the first quarter, helped by the drugmaker’s specialty medicines for HIV, cancer and immune diseases.
B
Bloomberg
April 29, 2026·1 min read
Image: Bloomberg
GSK Plc’s profit was higher than analysts expected in the first quarter, helped by the drugmaker’s specialty medicines for HIV, cancer and immune diseases.
Original article
GSK Profit Beats Estimates on HIV, Cancer Medicines
Published by Bloomberg